| scholarly article | Q13442814 |
| P50 | author | Ivan Bieche | Q56419632 |
| Sophie Vacher | Q87724233 | ||
| P2093 | author name string | Rosette Lidereau | |
| Carine Chavey | |||
| Gwendal Lazennec | |||
| Muriel Busson | |||
| Jean-Marc Guinebretière | |||
| Ludovic Le Corre | |||
| Catherine Andrieu | |||
| Sandrine Burlinchon | |||
| P433 | issue | 4 | |
| P304 | page(s) | 1039-1052 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | CXC chemokines located in the 4q21 region are up-regulated in breast cancer | |
| P478 | volume | 14 |
| Q36482032 | A CXCL1 paracrine network links cancer chemoresistance and metastasis |
| Q35683578 | A clinically relevant gene signature in triple negative and basal-like breast cancer |
| Q37207403 | A new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family |
| Q47275348 | A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment |
| Q38829768 | A screen for short-range paracrine interactions |
| Q35632602 | Aberrantly expressed mRNAs and long non-coding RNAs in patients with invasive ductal breast carcinoma: a pilot study |
| Q84933381 | Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines |
| Q36043058 | Acute impact of intermittent pneumatic leg compression frequency on limb hemodynamics, vascular function, and skeletal muscle gene expression in humans |
| Q39630347 | Analysis of chemokine and chemokine receptor expression in squamous cell carcinoma of the head and neck (SCCHN) cell lines |
| Q35511907 | Association of high expression of Groβ with clinical and pathological characteristics of unfavorable prognosis in gastrointestinal stromal tumors. |
| Q35600151 | Bioengineering embryonic stem cell microenvironments for the study of breast cancer |
| Q34130792 | Bone marrow-infiltrating human neuroblastoma cells express high levels of calprotectin and HLA-G proteins |
| Q39263970 | Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway. |
| Q24635943 | CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression |
| Q92238833 | CXCL13 and Its Receptor CXCR5 in Cancer: Inflammation, Immune Response, and Beyond |
| Q36964853 | CXCL3 contributes to CD133(+) CSCs maintenance and forms a positive feedback regulation loop with CD133 in HCC via Erk1/2 phosphorylation |
| Q41649318 | CXCL3 positively regulates adipogenic differentiation |
| Q33562564 | CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes. |
| Q30572945 | CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways |
| Q101226457 | Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype |
| Q37158424 | Cell density regulates cancer metastasis via the Hippo pathway |
| Q35577502 | Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling |
| Q34788410 | Chemokine (C-X-C) ligand 1 (CXCL1) protein expression is increased in aggressive bladder cancers |
| Q37694068 | Chemokines and chemokine receptors: new insights into cancer-related inflammation. |
| Q36918688 | Chemokines: novel targets for breast cancer metastasis |
| Q33656571 | Clinical omics analysis of colorectal cancer incorporating copy number aberrations and gene expression data |
| Q37223928 | Cytokine properties of prokineticins |
| Q57285709 | Detection of epigenetic field defects using a weighted epigenetic distance-based method |
| Q39738425 | Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival |
| Q36940505 | Differential response of bovine mammary epithelial cells to Staphylococcus aureus or Escherichia coli agonists of the innate immune system. |
| Q34119028 | ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches |
| Q34460058 | Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins |
| Q42660944 | Epidermal growth factor and estrogen act by independent pathways to additively promote the release of the angiogenic chemokine CXCL8 by breast tumor cells |
| Q37200903 | FGF18 as a prognostic and therapeutic biomarker in ovarian cancer |
| Q56979051 | Forkhead box C1 boosts triple-negative breast cancer metastasis through activating the transcription of chemokine receptor-4 |
| Q37439151 | Gene expression profiles of human adipose tissue-derived mesenchymal stem cells are modified by cell culture density |
| Q35884951 | Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern |
| Q35855332 | High incidence of triple negative breast cancers following pregnancy and an associated gene expression signature |
| Q34119025 | Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures |
| Q48131192 | Human Adipose-Derived Mesenchymal Stem Cell-Secreted CXCL1 and CXCL8 Facilitate Breast Tumor Growth By Promoting Angiogenesis |
| Q36557205 | IL-1β produced by aggressive breast cancer cells is one of the factors that dictate their interactions with mesenchymal stem cells through chemokine production |
| Q26851827 | Identifying and targeting tumor-initiating cells in the treatment of breast cancer |
| Q34977106 | Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS). |
| Q91584509 | Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy |
| Q35102469 | Interaction of aryl hydrocarbon receptor and NF-κB subunit RelB in breast cancer is associated with interleukin-8 overexpression. |
| Q39489370 | Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts |
| Q88208775 | Interleukin 8 in progression of hormone-dependent early breast cancer |
| Q42439415 | Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. |
| Q39729731 | Letrozole-induced functional changes in carcinoma-associated fibroblasts and their influence on breast cancer cell biology |
| Q36026081 | Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression |
| Q94591597 | Molecular profiling of stroma highlights stratifin as a novel biomarker of poor prognosis in pancreatic ductal adenocarcinoma |
| Q64245224 | Monoclonal Antibody against CXCL1 (HL2401) as a Novel Agent in Suppressing IL6 Expression and Tumoral Growth |
| Q38585102 | Neutrophils: important contributors to tumor progression and metastasis. |
| Q37153652 | Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells. |
| Q38797305 | Overexpression of CXCL3 can enhance the oncogenic potential of prostate cancer. |
| Q34471041 | Overexpression of chemokine ligand 7 is associated with the progression of canine transmissible venereal tumor. |
| Q55262341 | Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis. |
| Q36915870 | Polymorphisms in inflammation pathway genes and endometrial cancer risk |
| Q55209569 | Prognostic significance of CXCL5 expression in cancer patients: a meta-analysis. |
| Q33590672 | Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway |
| Q36289925 | Protein expression changes during human triple negative breast cancer cell line progression to lymph node metastasis in a xenografted model in nude mice |
| Q37690257 | Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells. |
| Q64238160 | Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5 |
| Q31106549 | SCOUP: a probabilistic model based on the Ornstein-Uhlenbeck process to analyze single-cell expression data during differentiation |
| Q31022986 | Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies. |
| Q39395370 | Stemness-related transcriptional factors and homing gene expression profiles in hepatic differentiation and cancer |
| Q35572396 | The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors |
| Q42371161 | The clinical and prognostic value of CXCL8 in cervical carcinoma patients: immunohistochemical analysis |
| Q89636461 | The health status alters the pituitary function and reproduction of mice in a Cxcr2-dependent manner |
| Q47398521 | Transcription factor c-Myb inhibits breast cancer lung metastasis by suppression of tumor cell seeding. |
Search more.